Stay updated on Pembrolizumab in Muscle-invasive Bladder Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Muscle-invasive Bladder Cancer Clinical Trial page.

Latest updates to the Pembrolizumab in Muscle-invasive Bladder Cancer Clinical Trial page
- Check6 days agoChange DetectedThe page now indicates recruitment has closed and adds new help sections (How to Read a Study Record, Common Questions, How to Join a Study). It also updates the Intervention/Treatment header formatting and the revision label to v3.6.0 (removing the previous v3.5.5).SummaryDifference0.5%

- Check13 days agoChange DetectedThe page's revision label updated from Revision: v3.5.4 to Revision: v3.5.5, indicating a minor update to the Study Details page. This likely reflects small fixes or clarifications rather than changes to the trial information.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check35 days agoChange DetectedThe page revision tag advanced from v3.5.3 to v3.5.4, signaling a minor update to the study record display and related metadata.SummaryDifference0.1%

- Check56 days agoChange DetectedThis updates the ClinicalTrials.gov page’s displayed revision/version number from v3.5.2 to v3.5.3, without changing any of the study details.SummaryDifference0.1%

- Check63 days agoChange DetectedA new publication reference was added to Publications, and the page revision was updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check92 days agoChange DetectedThe page now shows Revision: v3.5.0, replacing the previous Revision: v3.4.3.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab in Muscle-invasive Bladder Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Muscle-invasive Bladder Cancer Clinical Trial page.